BioCentury
ARTICLE | Clinical News

BCX4161: Preliminary Phase IIa data

June 2, 2014 7:00 AM UTC

Preliminary data from the crossover, German and U.K. Phase IIa OPuS-1 trial in 24 HAE patients with an attack frequency of >=1 attack per week showed that prophylactic treatment with thrice-daily 400 ...